Harrow Health Changes Corporate Name to Harrow Inc.

Harrow announced that effective today, it has changed its corporate name from “Harrow Health Inc.” to “Harrow Inc.” to align with the company’s current 5-year strategic plan, which includes an exclusive focus on eye care pharmaceuticals.

“Given the growing recognition of the Harrow name within the ophthalmic community, along with the connection of the Harrow brand to what is now one of the largest portfolios of ophthalmic pharmaceutical products in the US market, we believed it was the right time to represent our exclusive commitment to the ophthalmic market by shortening our corporate name to Harrow, Inc.,” Mark L. Baum, Chief Executive Officer of Harrow, said in a company news release. “Our team wakes up each day dedicated to serving the US ophthalmic community – to address their unmet needs and provide the highest quality ophthalmic products available, helping them preserve the gift of sight for their patients. This commitment has been part of Harrow’s DNA since our commercial founding in 2014, and it is one of the cornerstones of Harrow’s mission to make ophthalmic pharmaceutical products accessible and affordable to millions of Americans each year.”